Bio-Works Technologies AB: Outcome from Exercise of Warrants TO 2 Announced

Bio-Works Technologies AB has announced the results from the eighth and final exercise period for its Series TO 2 warrants. The company confirmed that the warrants, which provided the right to subscribe for new shares, have now expired.

The exercise period, which was the last for this series, concluded on October 14, 2026. The purpose of the warrant exercise was to potentially increase the company's share capital or reduce debt by allowing warrant holders to subscribe for new shares.

Bio-Works Technologies AB is focused on the development and manufacturing of biocides and other biomaterials. The company's technology utilizes renewable natural resources for industrial applications, offering alternatives to conventional chemical products.

Further details regarding the number of shares subscribed for or the total proceeds from the warrant exercise were not provided at this time. Additional information is expected in future financial reports.